Search research articles

相关概念视频

Statistical Software for Data Analysis and Clinical Trials

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Genome-scale metabolic models predict diet- and lifestyle-driven shifts of ecological interactions in the gut microbiome.

Gut microbes·2026

Same author

Combined periodontitis GWAS identifies LINC01541 as a regulator of innate immunity in the oral mucosa.

Human molecular genetics·2026

Same author

Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping.

Genomics, proteomics & bioinformatics·2026

Same author

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders.

Neurology(R) neuroimmunology & neuroinflammation·2026

Same author

Higher Redox State of Coenzyme Q10 Is Associated with Higher Risk of All-Cause Mortality in a Sample from the Northern German General Population.

Antioxidants (Basel, Switzerland)·2026

Same author

Dietary patterns influence the in silico GABA production capacity of Bifidobacterium adolescentis HD17T2H and other human gut bacteria.

Scientific reports·2026

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Updated: Jul 5, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

基于人口的生物银行.

Wolfgang Lieb^1,2,3, Eike A Strathmann¹, Christian Röder^1,3,4

¹Institute of Epidemiology and Biobank Popgen, Kiel University, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

|January 23, 2024

概括

基于人口的生物银行对医学研究至关重要,有众多的国家倡议和国际网络. 关键的挑战包括长期可持续性,管理偶然发现,以及生物库的数据链接.

关键词:

生物银行是生物银行.生物标志物生物标志物生物样本的生物样本临床常规临床常规队列研究是一项队列研究.治理治理治理治理治理治理健康数据健康数据现象型现象型是一种现象型.公众参与,公众参与.可持续性可持续性可持续性

更多相关视频

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Creation and Maintenance of a Living Biobank - How We Do It

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

相关实验视频

Last Updated: Jul 5, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Creation and Maintenance of a Living Biobank - How We Do It

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

科学领域:

生物医学研究的研究.
这是生物银行.
基因组学就是基因组学.

背景情况:

在过去的二十年中,基于人口的生物银行业已大幅扩展.
许多国家正在建立大型的国家生物银行计划.
像BBMRI-ERIC这样的网络活动在国家和国际层面上正在增加.

研究的目的:

描述基于人口的生物库可以解决的科学问题.
突出生物库在生物标志物发现和健康参数研究中的作用.
确定基于人口的生物银行的剩余挑战.

主要方法:

审查现有的基于人口的生物库和队列研究 (例如,UKBB,CONSTANCES,NAKO,LifeLines,FinnGen,我们所有人).
讨论科学应用,包括生物标志物发现和分子相关物.
确定生物库可持续性的挑战,偶然发现和数据链接.

主要成果:

基于人口的生物库有助于生物标志物的发现和校准.
它们可以识别健康和疾病的分子相关物.
虽然取得了重大进展,但仍然存在挑战.

结论:

基于人口的生物库对于推动医学研究至关重要.
解决可持续性,偶然发现和数据集成对于未来的成功至关重要.
持续的发展和网络是最大限度地提高生物银行影响的必要条件.